Epilepsy Pipeline Review, H1 2020 - AfaSci Inc, Biogen Inc, Cavion LLC, Ketogen Inc & Nissan Chemical Group - ResearchAndMarkets.com

DUBLIN--()--The "Epilepsy - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H1 2020, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape.

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Epilepsy - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Epilepsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Epilepsy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 7, 8, 28, 25, 4, 93, 24 and 6 respectively. Similarly, the Universities portfolio in IND/CTA Filed, Preclinical and Discovery stages comprises 2, 23 and 3 molecules, respectively.

Epilepsy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Epilepsy (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Epilepsy (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Epilepsy (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Epilepsy (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Epilepsy (Central Nervous System)

Reasons to buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Epilepsy (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Epilepsy (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Key Topics Covered:

  • Introduction
  • Epilepsy - Overview
  • Epilepsy - Therapeutics Development
  • Epilepsy - Therapeutics Assessment
  • Epilepsy - Companies Involved in Therapeutics Development
  • Epilepsy - Drug Profiles
  • Epilepsy - Dormant Projects
  • Epilepsy - Discontinued Products
  • Epilepsy - Product Development Milestones
  • Appendix

Companies Mentioned

  • Aadi Bioscience Inc
  • Advanced Neural Dynamics Inc
  • Advicenne SA
  • Aequus Pharmaceuticals Inc
  • AfaSci Inc
  • Affectis Pharmaceuticals AG
  • AgoneX Biopharmaceuticals Inc
  • AMO Pharma Ltd
  • Anavex Life Sciences Corp
  • Aphios Corp
  • Aquestive Therapeutics Inc
  • Asklepios BioPharmaceutical Inc
  • Aucta Pharmaceuticals LLC
  • Axium Pharmaceuticals Inc
  • B&A Therapeutics
  • BCWorld Pharm Co Ltd
  • Benuvia Therapeutics Inc
  • Bial - Portela & Ca SA
  • Bio-Pharm Solutions Co Ltd
  • Biogen Inc
  • Bioinnotis
  • BioLink Life Sciences Inc
  • Biovista Inc
  • Bloom Science Inc
  • Bristol-Myers Squibb Co
  • Cann Pharmaceutical Australia Ltd
  • Catalyst Pharmaceuticals Inc
  • Cavion LLC
  • Celavie Biosciences LLC
  • Cellix Bio Pvt Ltd
  • Cerebral Therapeutics Inc
  • Cerecin Inc
  • Cerevel Therapeutics LLC
  • Coda Biotherapeutics Inc
  • CombiGene AB
  • Crossject SA
  • CuroNZ Ltd
  • CURx Pharmaceuticals Inc
  • Cypralis Ltd
  • Eisai Co Ltd
  • Encoded Therapeutics Inc
  • Engage Therapeutics Inc
  • Epalex Corp
  • EpyGenix Therapeutics Inc
  • ES Therapeutics LLC
  • Eton Pharmaceuticals Inc
  • Ferring Pharmaceuticals Inc
  • GABA Therapeutics Inc
  • Genentech Inc
  • Generoath Co Ltd
  • Genus Lifesciences Inc
  • Gilead Sciences Inc
  • Glialogix Inc
  • Guangzhou Cellprotek Pharmaceutical Co Ltd
  • GW Pharmaceuticals Plc
  • Harvest One Cannabis Inc
  • Idorsia Pharmaceutical Ltd
  • Ionis Pharmaceuticals Inc
  • Iproteos SL
  • JC Pharma Inc
  • Johnson & Johnson
  • Karessa Pharma Holding AB
  • Ketogen Inc
  • Knopp Biosciences LLC
  • LATITUDE Pharmaceuticals Inc
  • Lead Discovery Center GmbH
  • LifeSplice Pharma LLC
  • Marinus Pharmaceuticals Inc
  • Medicure Inc
  • Medlab Clinical Ltd
  • Mercaptor Discoveries Inc
  • MGC Pharmaceuticals Ltd
  • Mucodel Pharma LLC
  • MyX Therapeutics Inc
  • NeuCyte Inc
  • NeurAegis Inc
  • Neurelis Inc
  • NeuroAdjuvants Inc
  • Neurocrine Biosciences Inc
  • NeuroCycle Therapeutics Inc
  • Neuroene Therapeutics LLC
  • Neurolink, Inc
  • Neuron Biopharma SA
  • Neurona Therapeutics Inc
  • New Amsterdam Sciences Inc
  • Nissan Chemical Corp
  • NoNO Inc
  • NuBioPharma LLC
  • OB Pharmaceuticals
  • OPKO Health Inc
  • Otsuka Holdings Co Ltd
  • Ovid Therapeutics Inc
  • OWP Pharmaceuticals Inc
  • Pairnomix LLC
  • Panaxia Pharmaceutical Industries Ltd
  • Panorama Research Inc
  • Pfizer Inc
  • PharmatrophiX Inc
  • Praxis Precision Medicines Australia Pty Ltd
  • Promius Pharma LLC
  • Proniras Corp
  • Proveca Ltd
  • PTC Therapeutics Inc
  • Recursion Pharmaceuticals Inc
  • reMYND NV
  • RogCon Inc
  • Sage Therapeutics Inc
  • Saniona AB
  • Scientus Pharma Inc
  • Sedor Pharmaceuticals LLC
  • Serina Therapeutics Inc
  • Simcere Pharmaceutical Group
  • SK Biopharmaceuticals Co Ltd
  • Stoke Therapeutics Inc
  • Suda Pharmaceuticals Ltd
  • Sumitomo Dainippon Pharma Co Ltd
  • Sun Pharma Advanced Research Company Ltd
  • Supernus Pharmaceuticals Inc
  • Sustained Nano Systems LLC
  • Taho Pharmaceuticals Ltd
  • Takeda Pharmaceutical Co Ltd
  • Techfields Pharma Co Ltd
  • The Cell Factory BVBA
  • Therapix Biosciences Ltd
  • UCB SA
  • Ultragenyx Pharmaceutical Inc
  • Valerion Therapeutics LLC
  • VistaGen Therapeutics Inc
  • Vitality Biopharma Inc
  • Xenon Pharmaceuticals Inc
  • XERIS Pharmaceuticals Inc
  • Xi'an Libang Pharmaceuticals Co Ltd
  • XW Laboratories Inc
  • Zhejiang Conba Pharmaceutical Co Ltd
  • Zogenix Inc
  • Zynerba Pharmaceuticals Inc

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/z9c77r

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900